AI assistant
Sending…
PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2012
Jun 11, 2012
33488_dirs_2012-06-11_9172609c-263f-454f-bbc9-6adcfa529cbe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2012-06-07
Reporting Person: Malley Thomas (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-07 | COMMON STOCK | P | 1800 | $12.50 | Acquired | 128351 | Direct |
| 2012-06-08 | COMMON STOCK | P | 8168 | $12.50 | Acquired | 136519 | Direct |
More from PUMA BIOTECHNOLOGY, INC.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8